Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ: SUPN · Real-Time Price · USD
31.16
-0.04 (-0.13%)
Jun 27, 2025, 4:00 PM - Market closed
Supernus Pharmaceuticals Employees
Supernus Pharmaceuticals had 674 employees as of December 31, 2024. The number of employees increased by 22 or 3.37% compared to the previous year.
Employees
674
Change (1Y)
22
Growth (1Y)
3.37%
Revenue / Employee
$991,093
Profits / Employee
$91,861
Market Cap
1.95B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
SUPN News
- 9 days ago - SAGE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sage Therapeutics, Inc. - SAGE - Business Wire
- 12 days ago - ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Sage Therapeutics, Inc. - PRNewsWire
- 12 days ago - Supernus Pharma to acquire Sage Therapeutics in up to $795 million deal - Reuters
- 12 days ago - Supernus Pharmaceuticals to Acquire Sage Therapeutics, Strengthening its Neuropsychiatry Product Portfolio - GlobeNewsWire
- 4 weeks ago - Jay Glazer and Wife Rosie Glazer Offer Candid Look at ADHD and Relationships in New Qelbree® Content Series with Supernus Pharmaceuticals - GlobeNewsWire
- 4 weeks ago - Supernus Announces Paragraph IV ANDA Filings for Qelbree® - GlobeNewsWire
- 4 weeks ago - Supernus to Participate in the 2025 Jefferies Global Healthcare Conference - GlobeNewsWire
- 7 weeks ago - Supernus Pharmaceuticals, Inc. (SUPN) Q1 2025 Earnings Call Transcript - Seeking Alpha